Observational Study
Copyright ©The Author(s) 2022.
World J Gastroenterol. Oct 28, 2022; 28(40): 5881-5892
Published online Oct 28, 2022. doi: 10.3748/wjg.v28.i40.5881
Table 3 Posttransplant outcomes (n = 235)

CC, n = 11 (4.5%)
DC, n = 129 (52.9%)
ACLF, n = 95 (38.9%)
P value
ICU stay (d) 2.0 (1.0-4.0) 2.0 (1.5-4.0) 3.0 (2.0-5.0) 0.05
Hospital stay (d) 6.0 (3.0-7.0)a7.0 (4.5-10.0) 8.0 (6.0-13.0)a0.01
Any type of complication, n (%)7 (63.6)105 (81.4)85 (89.5)0.05
Infectious complications, n (%)1 (9.1)a38 (29.5)b47 (49.5)a,b< 0.01
Complications (Clavien-Dindo), n (%)
I4 (36.4) 17 (13.2) 19 (20.0) 0.08
II2 (18.2) 51 (39.5) 32 (33.7) 0.31
III1 (9.1)14 (10.9)17 (17.9)0.27
IV0 (0.0)9 (7.0)12 (12.6)0.23
V0 (0.0)14 (10.9)5 (5.3)0.24